Table 7.
Obese participant demographic, anthropometric, and clinical characteristics according to vitamin B6 tertile of intake
| Variables | I tertile (n=19) 1.0 ± 0.1 mg/day | II tertile (n=19) 1.4 ± 0.1 mg/day | III tertile (n=20) 2.1 ± 0.3 mg/day | P-value | P-value Post-Hoc Analysis |
|---|---|---|---|---|---|
| Age (years) | 52 土 9 | 50 土 13 | 51 土 13 | 0.84 | NS |
| BMI (kg/m2) | 36 土 6 | 36 土 5 | 36 土 5 | 0.96 | NS |
| WC (cm) | 113 土 15 | 110 土 10 | 112 土 13 | 0.60 | NS |
| HC (cm) | 117 土 14 | 121 土 12 | 119 土 11 | 0.59 | NS |
| SBP (mmHg) | 127 土 10 | 127 土 10 | 137 土 15 | 0.010 | I vs. III 0.008 II vs. III 0.007 |
| DBP (mmHg) | 80 土 7 | 79 土 7 | 86 土 11 | 0.012 | I vs. III 0.001 II vs. III 0.005 |
| FFM (%) | 62 土 7 | 59 土 7 | 64 土 8 | 018 | NS |
| FM (%) | 38 土 7 | 40 土 7 | 36 土 8 | 0.18 | NS |
| CAP score (dB/m) | 263 土 46 | 268 土 40 | 297 土 47 | 0.038 | I vs. III 0.017 II vs. III 0.042 |
| Liver Stiffness (kPa) | 8.0 土 10 | 5.5 土 1.5 | 5.7 土 1.3 | 0.36 | NS |
| Glucose (mg/dL) | 97 土 14 | 91 土 11 | 98 土 11 | 0.21 | NS |
| Total cholesterol (mg/dL) | 196 土 42 | 198 土 35 | 198 土 34 | 0.98 | NS |
| HDL cholesterol (mg/dL) | 54 土 15 | 56 土 10 | 52 土 24 | 0.83 | NS |
| LDL cholesterol (mg/dL) | 114 土 33 | 116 土 30 | 112 土 39 | 0.92 | NS |
| Triglycerides (mg/dL) | 116 土 64 | 121 土 50 | 159 土 122 | 0.21 | NS |
| AST (IU/L) | 20 土 8 | 22 土 6 | 22 土 9 | 0.42 | NS |
| ALT (IU/L) | 23 土 14 | 22 土 10 | 27 土 19 | 0.86 | NS |
| Prevalence | |||||
| Hyperlipidemia (%) | 40 | 36 | 44 | 0.77 | |
| Hypertension (%) | 41 | 33 | 43 | 0.90 | |
| Smokers (%) | 41 | 29 | 48 | 0.67 |
BMI, body mass index; WC, waist circumferences; HC, hip circumferences; SBP, systolic blood pressure; DBP, diastolic blood pressure; FFM, free fat mass; FM, fat mass; CAP, controlled attenuation parameter; HDL, high density lipoprotein; LDL, low density lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; NS, non significant.